Value of a BRAFV600E and lymphocyte subset-based nomogram for discriminating benign lesions from papillary thyroid carcinoma in C-TIRADS 3 and higher nodules
The BRAF<sup>V600E</sup>-lymphocyte subset nomogram demonstrates robust clinical utility for discriminating benign lesions from PTC in C-TIRADS 3+ thyroid nodules, offering superior diagnostic performance to conventional risk stratification systems.
Authors
- Chengzhong Yu (ORCID: https://orcid.org/0000-0003-3707-0785)
- Jiaqing Dou
- Simei Zeng (ORCID: https://orcid.org/0000-0002-7532-3555)
- Wei Zhang (ORCID: https://orcid.org/0000-0001-7016-4922)
Institutions
- Chaohu Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-08-15
- DOI
- https://doi.org/10.3389/fendo.2025.1608222
- Citations
- 1
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- Anhui Provincial Department of Education